• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猪血管性血友病因子:多聚体群体。

Porcine Willebrand factor: a population of multimers.

作者信息

Fass D N, Knutson G J, Bowie E J

出版信息

J Lab Clin Med. 1978 Feb;91(2):307-20.

PMID:413873
Abstract

Purified porcine Willebrand factor was analyzed by agarose-sodium DodSO4 electrophoresis. Multiple forms of the protein were found in a series of increasing molecular weights. A molecular mass calibration curve was constructed with fibrinogen (3.4 X 10(5) daltons), IgM (1 X 10(6) daltons), and glutaraldehyde-crosslinked IgM polymers (2, 3, and 4 X 10(6) daltons). As measured by this procedure, the apparent molecular weight of Willebrand factor polymers ranged from 1.1 X 10(6) to 2.1 X 10(7). Each member of the series differed from one another by approximately 1.5 to 1.9 X 10(6) daltons, indicating that members of the series were polymers of 6-mers to 8-mers of the 2.3 X 10(5) dalton subunit. Various purification procedures, used to isolate Willebrand factor active in inducing platelet aggregation, were seen to fractionate the polymers, in part, on the basis of size. The same purification procedures, when applied to procine von Willebrand plasma, failed to yield protein of molecular weight greater than 1.1 X 10(6).

摘要

采用琼脂糖 - 十二烷基硫酸钠电泳法对纯化的猪血管性血友病因子进行分析。在一系列分子量逐渐增加的情况下发现了该蛋白质的多种形式。用纤维蛋白原(3.4×10⁵道尔顿)、免疫球蛋白M(1×10⁶道尔顿)和戊二醛交联的免疫球蛋白M聚合物(2×10⁶、3×10⁶和4×10⁶道尔顿)构建了分子量校准曲线。通过该方法测量,血管性血友病因子聚合物的表观分子量范围为1.1×10⁶至2.1×10⁷。该系列的每个成员彼此相差约1.5至1.9×10⁶道尔顿,表明该系列成员是由2.3×10⁵道尔顿亚基的6聚体至8聚体组成的聚合物。用于分离具有诱导血小板聚集活性的血管性血友病因子的各种纯化程序,部分是根据大小对聚合物进行分级分离。当将相同的纯化程序应用于猪血管性血友病血浆时,未能得到分子量大于1.1×10⁶的蛋白质。

相似文献

1
Porcine Willebrand factor: a population of multimers.猪血管性血友病因子:多聚体群体。
J Lab Clin Med. 1978 Feb;91(2):307-20.
2
Purification of porcine and human ristocetin-Willebrand factor.猪和人瑞斯托菌素-血管性血友病因子的纯化
J Lab Clin Med. 1977 Jun;89(6):1278-94.
3
Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.因子VIII/血管性血友病因子的二硫键与四级结构
J Clin Invest. 1978 Sep;62(3):702-9. doi: 10.1172/JCI109178.
4
Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules.低分子量人凝血因子VIII的血管性血友病因子活性通过与金颗粒结合而增加。
Thromb Haemost. 1981 Jun 30;45(3):242-6.
5
Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.人类抗血友病因子的研究。共价连接亚基结构的证据。
J Clin Invest. 1976 Apr;57(4):925-37. doi: 10.1172/JCI108369.
6
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.凝血因子VIII/血管性血友病因子蛋白。半乳糖是血管性血友病因子活性的一个隐蔽决定因素。
J Clin Invest. 1978 Aug;62(2):496-9. doi: 10.1172/JCI109152.
7
Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.纯化的大鼠因子VIII/血管性血友病因子与大鼠和人血小板的相互作用——白蛋白和瑞斯托菌素的影响
Thromb Haemost. 1984 Aug 31;52(1):57-9.
8
Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.人血浆中凝血因子 VIII 凝血蛋白的两种不同形式。凝血酶切割作用、凝血活性差异以及与血管性血友病因子的关联
J Clin Invest. 1984 Feb;73(2):307-16. doi: 10.1172/JCI111215.
9
Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.血管性血友病中凝血因子VIII/血管性血友病因子分子大小的异质性
Thromb Haemost. 1981 Jun 30;45(3):272-5.
10
Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.血管性血友病中因子VIII/血管性血友病因子的多聚体结构
J Lab Clin Med. 1980 Apr;95(4):590-602.

引用本文的文献

1
Isolation of functional human coagulation factor V by using a hybridoma antibody.利用杂交瘤抗体分离功能性人凝血因子V
Proc Natl Acad Sci U S A. 1981 Jan;78(1):162-6. doi: 10.1073/pnas.78.1.162.
2
Electron microscopy of human factor VIII/Von Willebrand glycoprotein: effect of reducing reagents on structure and function.人凝血因子VIII/血管性血友病糖蛋白的电子显微镜观察:还原剂对其结构和功能的影响
J Cell Biol. 1982 Nov;95(2 Pt 1):632-40. doi: 10.1083/jcb.95.2.632.
3
Analysis of factor VIII coagulant antigen in normal, thrombin-treated, and hemophilic plasma.
正常血浆、凝血酶处理血浆和血友病血浆中凝血因子 VIII 促凝抗原分析。
Proc Natl Acad Sci U S A. 1981 Aug;78(8):5137-41. doi: 10.1073/pnas.78.8.5137.
4
Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.血管性血友病:通过分析血浆和血小板中因子VIII/血管性血友病因子的多聚体组成来鉴定两种亚型
J Clin Invest. 1980 Jun;65(6):1318-25. doi: 10.1172/JCI109795.
5
Analysis of the complexity of the multimeric structure of factor VIII related antigen/von Willebrand protein using a modified electrophoretic technique.使用改良电泳技术分析因子VIII相关抗原/血管性血友病因子多聚体结构的复杂性。
J Clin Pathol. 1983 Aug;36(8):915-9. doi: 10.1136/jcp.36.8.915.
6
Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells.牛主动脉内皮细胞对凝血因子VIII R亚基的生物合成。
Proc Natl Acad Sci U S A. 1983 May;80(9):2738-42. doi: 10.1073/pnas.80.9.2738.
7
Transplantation of normal bone marrow into a pig with severe von Willebrand's disease.将正常骨髓移植到患有严重血管性血友病的猪体内。
J Clin Invest. 1986 Jul;78(1):26-30. doi: 10.1172/JCI112560.
8
Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.活化蛋白C对人凝血因子VIII的灭活作用。蛋白S的辅因子活性及血管性血友病因子的保护作用。
J Clin Invest. 1988 Oct;82(4):1236-43. doi: 10.1172/JCI113721.
9
Factor VIII/von Willebrand factor: a multivalent ligand binding to platelets and collagen.凝血因子VIII/血管性血友病因子:一种与血小板和胶原蛋白结合的多价配体。
Blut. 1986 Jun;52(6):329-36. doi: 10.1007/BF00320779.
10
Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein.牛血管性血友病因子(血小板聚集因子)的人血小板膜受体:一种整合膜糖蛋白。
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1069-73. doi: 10.1073/pnas.76.3.1069.